Loading organizations...
ProteoSource, LLC is a company.
Key people at ProteoSource, LLC.
ProteoSource, LLC operates as Silicon Valley Test & Measurement (SVTM), specializing in the acquisition and resale of used electronic test equipment. It provides access to high-quality, pre-owned instrumentation, offering a cost-effective solution for advanced technical needs. SVTM distributes reliable surplus equipment, often accompanied by warranties, serving a broad technical market by mitigating the expense of new units.
N. Stephen Pollitt founded ProteoSource, LLC, which established Silicon Valley Test & Measurement in 2015. Based in Los Altos, California, Pollitt’s insight addressed a market need for accessible, reliable electronic test equipment. He recognized the value in repurposing surplus instruments, thereby creating a streamlined channel for businesses and researchers to acquire essential tools.
The company serves various clients, including research institutions, technology firms, and individual engineers requiring precise measurement capabilities. ProteoSource, LLC’s vision is to empower innovation by providing cost-effective technical infrastructure. Extending the lifecycle of specialized equipment lowers barriers to advanced testing, fostering continued progress across engineering and scientific fields.
Key people at ProteoSource, LLC.
ProteoSource, LLC is a small holding company founded by N. Stephen Pollitt, operating primarily as a vehicle for business ventures including Silicon Valley Test & Measurement (SVTM), which specializes in affordable electronic test equipment.[1][3][7][9] It also has ties to protein production and microbial cell line engineering services for the biopharmaceutical and medical device industries, offering complete protein CMC (Chemistry, Manufacturing, and Controls) outsourcing.[6] The company, headquartered in the San Francisco Bay Area (with addresses in Mountain View and San Jose, CA), employs 1-4 people and generates under $500K in annual revenue within the consumer services industry.[2][3]
While not a traditional investment firm or high-growth startup, ProteoSource serves niche markets by consolidating Pollitt's entrepreneurial activities, solving problems in test equipment accessibility for electronics testing and specialized biotech protein production.[1][6][9] Its growth appears modest and operational rather than venture-backed, with a focus on practical outsourcing and equipment sales.[7]
ProteoSource, LLC was incorporated as a California Limited-Liability Company on January 26, 2010, by N. Stephen Pollitt, who serves as Founder, President, and key figure behind its operations.[1][3][5] Pollitt, based in Mountain View, CA, brings prior experience from roles likely in tech and engineering sectors, leveraging it to build ventures under the ProteoSource umbrella.[3] A pivotal element is its doing-business-as (DBA) relationship with Silicon Valley Test & Measurement (SVTM), which emerged as a core holding focused on electronic test equipment sales.[7][9]
The idea likely stemmed from Pollitt's expertise in addressing gaps in affordable testing tools and biotech services, with early traction through SVTM's product offerings and protein engineering for biopharma.[1][6] However, the company's formal status was listed as "Terminated" in California records, suggesting a possible pivot to informal operations or relocation post-2010.[5]
ProteoSource rides trends in affordable hardware for electronics prototyping and outsourced biotech R&D, capitalizing on Silicon Valley's ecosystem where startups need cost-effective test equipment amid chip shortages and AI hardware booms.[9] Timing aligns with post-2010 growth in SMB electronics testing and biopharma's push for rapid protein development, influenced by market forces like supply chain localization and CMC bottlenecks in drug manufacturing.[6][7] It influences the ecosystem modestly by enabling smaller players—engineers, device makers, and biopharma firms—to access specialized tools without enterprise-scale budgets, though its terminated CA status limits broader visibility.[5]
ProteoSource's path forward likely hinges on Pollitt's ability to sustain SVTM's equipment sales amid rising demand for edge AI testing and expand biotech outsourcing if regulatory tailwinds persist.[1][9] Trends like decentralized manufacturing and synthetic biology could amplify its niches, potentially evolving from a personal holding into a boutique service provider. Watch for reactivation or reincorporation signals, as its low-profile model positions it for steady, under-the-radar resilience rather than explosive growth—echoing its origins as a pragmatic venture consolidator.[3][5]